^
Association details:
Biomarker:No biomarker
Cancer:Vulvar Cancer
Regimen:GC (cisplatin + gemcitabine)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
04/26/2021
Excerpt:
Vulvar cancer (Squamous cell carcinoma): Advanced or recurrent/metastatic disease…Other recommended regimens…Cisplatin/gemcitabine (category 2B)